Skip to content

Long-Term Debt at other companies

IAR
Integra LifeSciencesIART
$1.75B+55.1%
MiMedx Group logo
MiMedx GroupMDXG
$16.09M-8.2%
Solventum logo
SolventumSOLV
$5.08B-35.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$49.64M
UFP Technologies logo
UFP TechnologiesUFPT
$125.11M-26.5%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
$2.01B+25.9%

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SecuredLongTermDebt.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s long-term debt?
SANUWAVE Health, Inc. (SNWV) reported long-term debt of $14.33M in Q1 2026.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.